SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

SEarchiNg biomarkErs Cerebral Amyloid Angiopathy (SENECA) — Stella

Recruiting

Back to Cerebral Amyloid Angiopathy trials

Trial locations(1 site)

Italy

UOC Neurologia 5, Milan, Milano

Key details

Sponsor

Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta

Enrollment target

~500 participants

Started

June 2020

Primary completion

May 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

55 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov